IP Verse

Bristol-Myers Squibb Co. V. Astrazeneca Pharmaceuticals Lp - 1:23-cv-00459

Explore the details of the Bristol-Myers Squibb Co. V. Astrazeneca Pharmaceuticals Lp case under case number 1:23-cv-00459 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:23-cv-00459
Filing Date
Apr 25, 2023
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent

Parties Involved in the Case

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Ono Pharmaceutical Co., Ltd. -
E. R. Squibb & Sons L.L.C. -
AstraZeneca Pharmaceuticals LP -
Dana-Farber Cancer Institute, Inc. -
Dr. Tasuku Honjo -
Bristol-Myers Squibb Co. -

Patents Involved in the Case

Patents not found - set an alert to get notified when patents are added.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

May 3, 2023Case Assigned to Judge Matthew F Kennelly of the United States District Court for the Northern District of Illinois (due to related cases). Please include the initials of the Judge (MFK) after the case number on all documents filed. (rjb)PACER Document
May 4, 2023MOTION for Pro Hac Vice Appearance of Attorney Shauna M. Kramer - filed by AstraZeneca Pharmaceuticals, LP, AstraZeneca UK Ltd., AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Joyce, Alexandra) (Entered: 05/04/2023)PACER Document
May 11, 2023STIPULATION and [Proposed] Order Regarding Service of Process on AstraZeneca UK Ltd. and to Extend Defendants' Response Time to Complaint by AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd.. (Joyce, Alexandra) (Entered: 05/11/2023)PACER Document
May 4, 2023SO ORDERED, regarding D.I. 13 MOTION for Pro Hac Vice Appearance of Attorney Shauna M. Kramer. Signed by Judge Matthew F Kennelly on 5/4/2023. (apk)PACER Document
May 10, 2023Pro Hac Vice Attorney Shauna M. Kramer for AstraZeneca Pharmaceuticals, LP and AstraZeneca UK Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:22-cv-00346-MFK, 1:23-cv-00079-MFK, 1:23-cv-00459-MFK(mpb)PACER Document
May 11, 2023SO ORDERED, regarding D.I. 14 Stipulation filed by AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd. (Notice of Compliance deadline set for 5/31/2023.) Signed by Judge Matthew F Kennelly on 5/11/2023. (apk) (Entered: 05/11/2023)PACER Document
Apr 25, 2023COMPLAINT filed with Jury Demand against AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd. (Filing fee $ 402, receipt number ADEDC-4121034) - filed by Tasuku Honjo, Bristol-Myers Squibb Co., Ono Pharmaceutical Co., Ltd., E. R. Squibb & Sons L.L.C., and Dana-Farber Cancer Institute, Inc. (Attachments: # 1 Exhibit 1, # 2 Civil Cover Sheet) (mkr) (Entered: 04/25/2023)Attachment
Apr 25, 2023COMPLAINT filed with Jury Demand against AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd. (Filing fee $ 402, receipt number ADEDC-4121034) - filed by Tasuku Honjo, Bristol-Myers Squibb Co., Ono Pharmaceutical Co., Ltd., E. R. Squibb & Sons L.L.C., and Dana-Farber Cancer Institute, Inc. (Attachments: # 1 Exhibit 1, # 2 Civil Cover Sheet) (mkr) (Entered: 04/25/2023)Attachment
May 30, 2023STIPULATION TO EXTEND TIME the Deadline for AstraZeneca Pharmaceuticals LP and AstraZeneca UK Ltd. to Answer, Move or Otherwise Respond to the Complaint to June 7, 2023 - filed by AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd.. (Joyce, Alexandra) (Entered: 05/30/2023)PACER Document
May 31, 2023STIPULATION and Proposed Order Regarding Case Consolidation by Bristol-Myers Squibb Co., E. R. Squibb & Sons, L.L.C., Dana-Farber Cancer Institute, Inc., Tasuku Honjo, Ono Pharmaceutical Co., Ltd.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Farnan, Michael) (Entered: 05/31/2023)PACER Document
Jun 5, 2023SO ORDERED, re 17 STIPULATION and Proposed Order Regarding Case Consolidation. Pursuant to Federal Rule of Civil Procedure 42(a), C.A. No. 22-cv-346-MFK and C.A. No. 23-cv-459-MFK are consolidated for all purposes up to and including trial. C.A. No. 22-cv-346-MFK shall be the lead case and all papers shall be filed in C.A. No. 22-cv-346-MFK (consolidated). Signed by Judge Matthew F Kennelly on 6/5/2023. (twk) (Main Document 18 replaced on 6/5/2023) (twk). (Entered: 06/05/2023)PACER Document
Jun 8, 2023SO ORDERED, re 16 STIPULATION TO EXTEND TIME the Deadline for AstraZeneca Pharmaceuticals LP and AstraZeneca UK Ltd. to Answer, Move or Otherwise Respond to the Complaint to June 7, 2023. Ordered by Judge Matthew F Kennelly on 6/8/2023. (twk) (Entered: 06/08/2023)PACER Document
Jul 28, 2023STIPULATION of Dismissal by Bristol-Myers Squibb Co., Dana-Farber Cancer Institute, Inc., E. R. Squibb & Sons, L.L.C., Tasuku Honjo, Ono Pharmaceutical Co., Ltd.. (Farnan, Michael) (Entered: 07/28/2023)PACER Document
Jul 31, 2023Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) See Attached. (smg) (Entered: 07/31/2023)PACER Document
Jul 31, 2023SO ORDERED, re (20 in 1:23-cv-00459-MFK, 179 in 1:22-cv-00346-MFK) Stipulation of Dismissal (CASE CLOSED) Ordered by Judge Matthew F Kennelly on 07/31/2023. Associated Cases: 1:22-cv-00346-MFK, 1:23-cv-00459-MFK(smg) (Entered: 07/31/2023)PACER Document